In TBI models, acute NOX2 inhibition reduced cognitive impairment and reduced lesion volume [28–30], although Kumar et al. found that inhibition of NOX2 from 1 to 3 days post-injury was not as effective at improving post-TBI function as NOX2 KO. This evidence concerns the gene CYBB and Cognitive impairment.